Xinling Medtech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Xinling Medtech General Information

Description

Developer of percutaneous ventricular assist device (pVAD). The company develops affordable pVAD for high risk percutaneous coronary intervention, enabling patients with cardiogenic shock and heart failure to get better treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit E463, 5th Floor, Lecheng Plaza, Phase II
  • Biopharmaceutical Industrial Park, No. 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Surgical Devices
Corporate Office
  • Unit E463, 5th Floor, Lecheng Plaza, Phase II
  • Biopharmaceutical Industrial Park, No. 218 Xinghu Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xinling Medtech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 22-Oct-2024 Completed Clinical Trials - General
3. Early Stage VC (Series A1) 25-Jan-2022 Completed Clinical Trials - General
2. Early Stage VC (Series A) 25-Sep-2021 $15.5M $15.5M Completed Pre-Clinical Trials
1. Early Stage VC 23-Mar-2021 Completed Pre-Clinical Trials
To view Xinling Medtech’s complete valuation and funding history, request access »

Xinling Medtech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Creation Investment Management Venture Capital Minority
Hangzhou Simiao Equity Investment Growth/Expansion Minority
Alwin Capital Venture Capital Minority
TF Capital Venture Capital Minority
To view Xinling Medtech’s complete investors history, request access »

Ready to get started?

Request a free trial

Xinling Medtech FAQs

  • When was Xinling Medtech founded?

    Xinling Medtech was founded in 2020.

  • Where is Xinling Medtech headquartered?

    Xinling Medtech is headquartered in Suzhou, China.

  • What industry is Xinling Medtech in?

    Xinling Medtech’s primary industry is Surgical Devices.

  • Is Xinling Medtech a private or public company?

    Xinling Medtech is a Private company.

  • What is Xinling Medtech’s current revenue?

    The current revenue for Xinling Medtech is .

  • How much funding has Xinling Medtech raised over time?

    Xinling Medtech has raised $31.2M.

  • Who are Xinling Medtech’s investors?

    Shanghai Creation Investment Management, Hangzhou Simiao Equity Investment, Alwin Capital, and TF Capital have invested in Xinling Medtech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process